Macro Group Pharmaceuticals (Macro Capital) S.A.E reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was EGP 134.91 million compared to EGP 117.92 million a year ago. Net income was EGP 31.09 million compared to EGP 11.69 million a year ago. Basic earnings per share from continuing operations was EGP 0.05 compared to EGP 0.02 a year ago. Diluted earnings per share from continuing operations was EGP 0.05 compared to EGP 0.02 a year ago.